ReviewBlood and lymphatic cancer : targets and therapy2016

Ruxolitinib: a targeted treatment option for patients with polycythemia vera.

Kris Vaddi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.